丹麦两个高龄出生队列生命最后数年的处方药使用比较
该研究基于丹麦全国登记数据,比较1905和1915两个出生队列在1995至2012年间生命最后数年的处方药使用。两个队列的用药种类均随死亡临近和日历年份增加而上升,1915队列显著高于1905队列;90岁临终者平均用药从1995年的6.0种增至2005年的8.7种,多重用药比例从63%升至82%。
要点
- 高龄老人生命最后数年处方药种类随死亡临近和日历年份增加而上升。
- 1915出生队列的处方药使用明显高于1905出生队列。
- 2005年90岁临终者多重用药比例达82%,高于1995年的63%。
核心结论
- 两个相隔10年的丹麦高龄出生队列中,生命最后数年的处方药使用持续加速上升,且较近队列使用量显著更大。
- 该趋势提示1995至2012年间用药方案增加,凸显对生命最后数年高龄脆弱人群制定循证用药指南的必要性。
研究设计与样本
- 基于丹麦全国登记数据,评估1905和1915两个完整出生队列在1995至2012年间生命最后数年的处方药使用。
- 用药量化为截至给定日期前120天内不同药房调配药物种类数。
主要发现
- 两个队列的处方药使用均随死亡临近和日历年份增加而上升,死亡年龄影响很小。
- 1915队列的处方药使用显著高于1905队列。
- 平均处方药种类数因年龄、日历年份和死亡临近程度不同,从低于3种到高于9种不等。
- 1995至2005年,90岁临终者最后一个月平均处方药种类从6.0增至8.7。
- 2005年死亡的90岁者中82%存在多重用药,1995年为63%。
临床怎么用
- 对生命最后数年的高龄患者应定期审查用药方案,关注多重用药随死亡临近而增加的趋势。
- 临床决策需权衡积极治疗与潜在过度治疗,尤其在高龄脆弱人群的临终阶段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Age limits for diagnostics and treatments have been largely removed and replaced by an active diagnostic and treatment practice among the oldest old and has led to concerns about potential overtreatment during the last years of life. METHODS: Use of prescription medication in the last years of life was assessed from 1995 to 2012 for the entire 1905 and 1915 Danish birth cohorts using nationwide register data. Medication use was quantified as the number different pharmacy-redeemed drugs during 120 days up to a given date. RESULTS: For both cohorts, prescription medication use increased with proximity to death and calendar year, while age at death had little impact; use in the 1915 cohort was markedly higher than in the 1905 cohort. Average number of prescription medications varied from below 3 to above 9 depending on age, calendar year and proximity to death. From 1995 to 2005, average number of prescription medications for a 90-year-old person in the last month of life increased from 6.0 to 8.7. Out of 90-year-old persons dying in 2005, 82% were exposed to polypharmacy, up from 63% in 1995. CONCLUSIONS: Prescription medication use accelerates throughout the last of years life among two Danish oldest old cohorts born 10 years apart, with substantially larger use in the most recent cohort. This pattern suggests an increase in drug prescribing regimens in the period 1995-2012, reinforcing the need for evidence-based guidelines on medications in the particularly vulnerable population of the oldest old patients in their last years of life.
引用
- Pedersen JK, Jensen TM, Waldorff FB, et al. Use of prescription medication in the last years of life: a population-based comparison of two oldest old Danish birth cohorts born 10 years apart. Age Ageing. 2020. PMID: 32315400. doi:10.1093/ageing/afaa064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。